The Patterns of Treatment Modality and Survival Outcome in Patients with Hepatocellular Carcinoma Accompanying Portal Vein Invasion in Korea: A Multicenter Prospective Cohort Study

被引:0
|
作者
Paik, Yong-Han [1 ]
Sinn, Dong Hyun [2 ]
Lee, Hye Won [3 ]
Kim, Do Young [4 ]
Kim, Yoon Jun [5 ,6 ]
Kim, Kang Mo [7 ]
Bae, Si Hyun [8 ]
Kim, Ji Hoon [9 ]
Seo, Yeon Seok [10 ]
Jang, Jae Young [11 ]
Jang, Byoung Kuk [12 ]
Yim, Hyung Joon [13 ]
Kim, Hyung Joon [14 ]
Lee, Byung Seok [15 ]
Kim, Bo Hyun
Kim, In Hee [16 ]
Cho, Eun-Young [17 ]
Lee, Jung Il [18 ]
Suh, Kyung-Suk [19 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Med, Seoul, South Korea
[3] Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea
[4] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[5] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
[6] Seoul Natl Univ Hosp, Liver Res Inst, Seoul, South Korea
[7] Univ Ulsan, Coll Med, Asan Med Ctr, Gastroenterol, Ulsan, South Korea
[8] Catholic Univ, Coll Med, Seoul, South Korea
[9] Korea Univ, Med Coll, Seoul, South Korea
[10] Korea Univ, Coll Med, Internal Med, Seoul, South Korea
[11] Soonchunhyang Univ, Med Coll, Internal Med, Asan, South Korea
[12] Keimyung Univ, Sch Med, Daegu, South Korea
[13] Korea Univ, Coll Med, Seoul, South Korea
[14] Chung Ang Univ, Coll Med, Seoul, South Korea
[15] Chungnam Natl Univ, Coll Med, Daejeon, South Korea
[16] Chonbuk Natl Univ, Jeonju, South Korea
[17] Wonkwang Univ, Coll Med, Iksan, South Korea
[18] Yonsei Univ, Coll Med, Seoul, South Korea
[19] Seoul Natl Univ Hosp, Dept Surg, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1511
引用
收藏
页码:861A / 862A
页数:2
相关论文
共 50 条
  • [31] Microscopic Portal Vein Invasion in Relation to Tumor Focality and Dimension in Patients with Hepatocellular Carcinoma
    Carr, Brian, I
    Guerra, Vito
    Donghia, Rossella
    Ince, Volkan
    Akbulut, Sami
    Ersan, Veysel
    Usta, Sertac
    Isik, Burak
    Samdanci, Emine
    Yilmaz, Sezai
    JOURNAL OF GASTROINTESTINAL SURGERY, 2022, 26 (02) : 333 - 340
  • [32] Bevacizumab in hepatocellular carcinoma in patients without metastasis and without invasion of the portal vein.
    Schwartz, JD
    Schwartz, M
    Goldman, J
    Lehrer, D
    Coll, D
    Kinkabwala, M
    Wadler, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 335S - 335S
  • [33] Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein
    Fan, J
    Wu, ZQ
    Tang, ZY
    Zhou, J
    Qiu, SJ
    Ma, ZC
    Zhou, XD
    Ye, SL
    WORLD JOURNAL OF GASTROENTEROLOGY, 2001, 7 (01) : 28 - 32
  • [34] Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein
    Jia Fan
    Zhi Quan Wu
    Zhao You Tang
    Jian Zhou
    Shuang Jian Qiu
    Zeng Chen Ma
    Xin Da Zhou
    Sheng Long Ye Liver Cancer Institute
    World Journal of Gastroenterology, 2001, (01) : 28 - 32
  • [35] Postoperative adjuvant transarterial chemoembolisation improves survival of hepatocellular carcinoma patients with microvascular invasion: A multicenter retrospective cohort
    Luo, Laihui
    Shan, Renfeng
    Cui, Lifeng
    Wu, Zhao
    Qian, Junlin
    Tu, Shuju
    Zhang, WenJian
    Xiong, Yuanpeng
    Lin, Wei
    Tang, Hongtao
    Zhang, Yang
    Zhu, Jisheng
    Huang, Zeyu
    Li, Zhigang
    Mao, Shengping
    Li, Hui
    Hu, Zemin
    Peng, Peng
    He, Kun
    Li, Yong
    Liu, Liping
    Shen, Wei
    He, Yongzhu
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2023, : 228 - 241
  • [36] Preclinical study of c-Met inhibitor as an adjuvant treatment for hepatocellular carcinoma with macroscopic portal vein invasion
    Kokudo, Takashi
    Inagaki, Yoshinori
    Hasegawa, Kiyoshi
    Shirata, Chikara
    Amikura, Katsumi
    Takahashi, Amane
    Kaneko, Junichi
    Akamatsu, Nobuhisa
    Arita, Junichi
    Sakamoto, Yoshihiro
    Sakamoto, Hirohiko
    Kokudo, Norihiro
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [37] Effect of postoperative apatinib treatment after resection of hepatocellular carcinoma with portal vein invasion: A phase II study
    Sun, Hui-Chuan
    Zhu, Xiao-Dong
    Zhou, Jian
    Gao, Qiang
    Shi, Ying-Hong
    Ding, Zhen-Bing
    Huang, Cheng
    Qiu, Shuang-Jian
    Ren, Ning
    Shi, Guo-Ming
    Sun, Jian
    Ye, Qing-Hai
    Huang, Xiao-Wu
    Yang, Xin-Rong
    Fan, Jia
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [38] Randomized prospective study of prevention from tumor invasion into portal vein in 120 patients with hepatocellular carcinoma by vitamin K-II administration
    Koike, Y
    Shiratori, Y
    Shiina, S
    Teratani, T
    Obi, S
    Sato, S
    Hamamura, K
    Akamatsu, M
    Tateishi, R
    Fujishima, T
    Yoshida, H
    Ishikawa, T
    Kawase, T
    Omata, M
    GASTROENTEROLOGY, 2002, 122 (04) : A643 - A643
  • [39] The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction - A prospective controlled study
    Lee, HS
    Kim, JS
    Choi, IJ
    Chung, JW
    Park, JH
    Kim, CY
    CANCER, 1997, 79 (11) : 2087 - 2094
  • [40] The prospective national intersectoral cohort study JADE to study characteristics, treatment and outcome of patients with hepatocellular or cholangiocellular carcinoma in Germany
    Thimme, R.
    Schroeder, J.
    Uhlig, J.
    Freiberg-Richter, J.
    Zingerle, M.
    Schlenska-Lange, A.
    Hering-Schubert, C.
    Potthoff, K.
    Bengsch, F.
    Hillebrand, L. E.
    Siebenbach, H. U.
    Janicke, M.
    Hofmann, W. P.
    Pereira, P.
    Berg, T.
    Galle, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 33 - 33